US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 0.916
  • +0.059+6.90%
Close Aug 8 16:00 ET
  • 0.910
  • -0.006-0.66%
Post 19:59 ET
190.73MMarket Cap-663P/E (TTM)

Sangamo Therapeutics Key Stats

Sangamo Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 6, 2024

Revenue(YoY)

356.00K

-94.79%
EPS(YoY)

-0.18

+72.73%

Buy

Aug 7, 2024

Sangamo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.980M--
--2024/Q3-- / 16.700M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.980M--
--2024/Q3-- / 16.700M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--

Unlock Free Earnings Estimates

Sangamo Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Aug 7, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg